Outcomes for [177Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer. - Muniz M; Sartor O; Orme JJ; Koch RM; Scharf Z; Heath EI; Zarka JG; Kase AM; Riaz IB; Andrews JR; Thorpe MP; Tuba Kendi A; et al. (European urology oncology, 2025)